We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-1.83%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$696M
AUM Growth
-$17.3M
Cap. Flow
-$537K
Cap. Flow %
-0.08%
Top 10 Hldgs %
15.81%
Holding
288
New
40
Increased
95
Reduced
57
Closed
17

Top Buys

Rank Stock Value
1
FRSH icon
Freshworks
FRSH
+$10.8M
2
JBL icon
Jabil
JBL
+$4.39M
3
GSK icon
GSK
GSK
+$4.1M
4
NOV icon
NOV
NOV
+$3.97M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.76M

Sector Composition

Rank Sector Weight
1 Technology 31.67%
2 Industrials 12.69%
3 Healthcare 11.3%
4 Energy 7.93%
5 Financials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
26
Applied Materials
AMAT
$426B
$5.72M 0.82%
24,257
+3,165
+15% +$679K
MCK icon
27
McKesson
MCK
$98.5B
$5.49M 0.79%
9,392
+247
+3% +$138K
PATH icon
28
UiPath
PATH
$5.62B
$5.48M 0.79%
432,464
+102,040
+31% +$1.76M
QCOM icon
29
Qualcomm
QCOM
$176B
$5.39M 0.77%
27,059
+750
+3% +$142K
NXPI icon
30
NXP Semiconductors
NXPI
$68B
$5.24M 0.75%
19,490
+809
+4% +$209K
AIR icon
31
AAR Corp
AIR
$5.15B
$5.14M 0.74%
70,714
-836
-1% -$56.7K
TTWO icon
32
Take-Two Interactive
TTWO
$43B
$5.14M 0.74%
33,057
-6
-0% -$910
WM icon
33
Waste Management
WM
$95.9B
$5.1M 0.73%
23,927
+1,046
+5% +$217K
FLR icon
34
Fluor
FLR
$7.29B
$4.99M 0.72%
114,662
-4,467
-4% -$186K
KEX icon
35
Kirby Corp
KEX
$7.95B
$4.94M 0.71%
41,271
-500
-1% -$55.9K
HON icon
36
Honeywell
HON
$77B
$4.9M 0.7%
24,348
+552
+2% +$105K
LLY icon
37
Eli Lilly
LLY
$1.07T
$4.87M 0.7%
5,383
-4,438
-45% -$3.55M
AZN icon
38
AstraZeneca
AZN
$263B
$4.86M 0.7%
31,165
+1,338
+4% +$201K
TJX icon
39
TJX Companies
TJX
$170B
$4.86M 0.7%
44,125
+2,060
+5% +$207K
PCTY icon
40
Paylocity
PCTY
$6.71B
$4.86M 0.7%
36,844
-2,977
-7% -$461K
MA icon
41
Mastercard
MA
$477B
$4.83M 0.69%
10,958
+369
+3% +$168K
PAYC icon
42
Paycom
PAYC
$6.78B
$4.82M 0.69%
33,723
-2,819
-8% -$483K
P
43
Everpure Inc
P
$24.8B
$4.78M 0.69%
74,501
-7,615
-9% -$441K
BILL icon
44
BILL Holdings
BILL
$4.33B
$4.78M 0.69%
90,860
-9,058
-9% -$513K
GTM
45
ZoomInfo Technologies
GTM
$861M
$4.74M 0.68%
371,526
-34,473
-8% -$482K
VOO icon
46
Vanguard S&P 500 ETF
VOO
$968B
$4.64M 0.67%
9,284
+3,097
+50% +$1.49M
OWL icon
47
Blue Owl Capital
OWL
$6.39B
$4.59M 0.66%
258,310
+11,205
+5% +$206K
EXAS
48
DELISTED
Exact Sciences
EXAS
$4.58M 0.66%
108,418
-10,272
-9% -$565K
CFLT
49
DELISTED
Confluent
CFLT
$4.49M 0.65%
152,055
-12,496
-8% -$359K
SDGR icon
50
Schrodinger
SDGR
$1.12B
$4.47M 0.64%
231,224
-22,130
-9% -$510K

Similar funds

Stanley-Laman Group's Q2 2024 Portfolio in Review

As of Q2 2024, Stanley-Laman Group held 288 positions worth $696M, down 2.4% from $713M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q2 2024 filing shows 40 new, 95 increased, 57 reduced and 17 closed positions. Its largest new stake was Freshworks: 719,687 shares worth $9.13M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q2 2024 buy was Freshworks: 719,687 shares worth $9.13M.
  • Stanley-Laman Group added most to GSK in Q2 2024, an estimated $4.1M increase.
  • Stanley-Laman Group's biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $3.55M.
  • Stanley-Laman Group fully exited HashiCorp, Inc. Class A Common Stock in Q2 2024, selling an estimated $11.3M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $696M portfolio in Q2 2024.
  • Stanley-Laman Group opened 40 new positions and closed 17 in Q2 2024.
  • Stanley-Laman Group's portfolio value fell 2.4% quarter-over-quarter to $696M.

Based on Stanley-Laman Group's 13F filing for Q2 2024, filed 18 Jul 2024.